Collaboration to Distribute Mycoplasma Detection Assays

(San Diego, CA, USA).

Mycoplasma contamination is one of the most challenging problems in biopharmaceutical manufacturing, since it is difficult to detect and remove from cell lines. The partners maintain that the new agreement will combine the easy-to-use DNA probe-based MTC-NI system with Millipore's sample preparation products and application knowledge to quickly and cost-effectively detect mycoplasma.

"The expansion of our partnership with Gen-Probe reflects our conviction in the long-term potential for developing faster and more accurate detection of microorganisms in biopharmaceutical production,” said Jean-Paul Mangeolle, president of Millipore's bioprocess division. "We are now able to package MTC-NI tests with our mycoplasma clearance products to meet customers' immediate needs, while strengthening relationships and gaining feedback that will help us to develop and sell our next-generation of nucleic acid tests.”

"We are pleased with the expansion of our Millipore collaboration, which we believe will drive sales of our existing MTC-NI product while also paving the way for adoption of the more rapid and sensitive next-generation products,” said Lynda Merrill, Gen-Probe's vice-president of industrial relationships.


Related Links:
Millipore
Gen-Probe Inc.